Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sustained delivery of vemurafenib using polymeric nanocapsules induces apoptosis in anaplastic thyroid carcinoma (8305C cancer cells).

Scientific reports·2026
Same author

Correction: Barani et al. Nanomaterials in the Management of Gram-Negative Bacterial Infections. <i>Nanomaterials</i> 2021, <i>11</i>, 2535.

Nanomaterials (Basel, Switzerland)·2026
Same author

A machine learning and physics-informed framework for predictive modeling of gemcitabine nanocomposite cytotoxicity.

Computational biology and chemistry·2026
Same author

Electrospun polyurethane-eggshell membrane hybrid nanofibrous scaffolds for enhanced fibroblast adhesion and growth in skin tissue engineering.

Scientific reports·2026
Same author

Hybrid physics-informed machine learning and nanobiosensing strategies for precision liver cancer diagnostics.

Computational biology and chemistry·2026
Same author

A physics-informed machine learning framework for predicting and mitigating doxorubicin nanocarrier toxicity in normal cells.

Scientific reports·2026
Same journal

Steroid-induced tumor lysis syndrome in solid tumors: A case report and review of the literature.

Seminars in oncology·2026
Same journal

PSMA PET/CT staging in intermediate-risk prostate cancer: Toward risk-adapted implementation.

Seminars in oncology·2026
Same journal

Angiogenesis and the corresponding antiangiogenic therapy in gastroenteropancreatic neuroendocrine neoplasms.

Seminars in oncology·2026
Same journal

Post-translational regulation of steroidogenesis and its clinical relevance in hormone responsive cancers.

Seminars in oncology·2026
Same journal

Stoma-free precision sphincter-preserving surgery with J-pouch for metastatic low rectal neuroendocrine tumor.

Seminars in oncology·2026
Same journal

FDA approval of avutometinib + defactinib (Avmapki Fakzynja) for KRAS-mutant LGSOC: A precision oncology milestone.

Seminars in oncology·2026
See all related articles

Related Experiment Video

Updated: May 31, 2026

Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography
09:53

Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography

Published on: August 16, 2020

Physics-informed machine learning for tumor microenvironment-responsive nanomedicine: Recent updates.

Maliheh Hasannia1, Ali Abounoori2, Mahdi Abounoori1

  • 1Cancer Research Center, Semnan University of Medical Sciences, Semnan, Iran.

Seminars in Oncology
|May 29, 2026
PubMed
Summary
This summary is machine-generated.

Physics-informed machine learning (PIML) enables personalized cancer nanomedicine by integrating physical laws with sparse data to model the tumor microenvironment (TME). This approach overcomes data scarcity for tailored nanomedicine design and therapy prediction.

Keywords:
Multi-omics integrationNanomedicineNanoparticle transportPhysics-informed machine learningTumor microenvironment

More Related Videos

Expanding the Comprehension of the Tumor Microenvironment using Mass Spectrometry Imaging of Formalin-Fixed and Paraffin-Embedded Tissue Samples
06:47

Expanding the Comprehension of the Tumor Microenvironment using Mass Spectrometry Imaging of Formalin-Fixed and Paraffin-Embedded Tissue Samples

Published on: June 29, 2022

Related Experiment Videos

Last Updated: May 31, 2026

Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography
09:53

Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography

Published on: August 16, 2020

Expanding the Comprehension of the Tumor Microenvironment using Mass Spectrometry Imaging of Formalin-Fixed and Paraffin-Embedded Tissue Samples
06:47

Expanding the Comprehension of the Tumor Microenvironment using Mass Spectrometry Imaging of Formalin-Fixed and Paraffin-Embedded Tissue Samples

Published on: June 29, 2022

Area of Science:

  • Biomedical Engineering
  • Computational Biology
  • Nanotechnology

Background:

  • Physics-informed machine learning (PIML) is emerging for nanomedicine design.
  • Existing reviews cover broader biomedical applications, lacking focus on TME biophysics and nanomedicine.
  • The personalization paradox in oncology highlights the need for patient-specific models with limited data.

Purpose of the Study:

  • To provide a focused synthesis of PIML at the intersection of TME biophysics and nanomedicine design.
  • To articulate a translational roadmap linking PIML methodologies to nanomedicine optimization tasks.
  • To introduce a comparative framework evaluating PIML against other approaches for TME applications.

Main Methods:

  • Embedding governing physical laws (e.g., Darcy's flow, reaction-diffusion, Navier-Stokes) as soft constraints in PIML models.
  • Developing PIML models for predicting nanoparticle transport in heterogeneous TMEs.
  • Designing stimulus-responsive nanocarriers and integrating multi-omics/imaging data for personalized therapy.
  • Comparing PIML with purely physics-based and data-driven methods.

Main Results:

  • PIML models can generate physically plausible, patient-tailored predictions using sparse clinical data.
  • PIML demonstrates superior data efficiency and interpretability for TME applications compared to traditional methods.
  • Identified key nanomedicine optimization tasks addressable by PIML, including transport prediction and nanocarrier design.

Conclusions:

  • PIML offers a powerful solution to the personalization paradox in oncology nanomedicine.
  • Significant challenges include data standardization, computational scalability, and regulatory adaptation.
  • Future directions include quantum-informed PIML, digital twins for adaptive therapy, and ethical-regulatory frameworks for clinical deployment.